Clinical Trial: Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804576) titled 'Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH' on Aug. 17.

Brief Summary: To study the effect of a re-ascent to high altitude (Quito Ecuador: 2850m) after a one-week stay at sea level (after prior descent from 2850m) on lung function and pulmonary resistance/reactance in patients with pulmonary arterial disease PAH, who live permanently > 2600m.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: Pulmonary Arterial Hypertension (PAH) Pulmonary Vascular Disease High Altitude Effects High Altitude Lung Function Testing Lung Function Changes...